by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan. Read More
by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles Dr. Shirley D’Sa discusses the importance of catching peripheral neuropathy in patients with Waldenstrom macroglobulinemia early on, and how to treat it. Read More
by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles The phase 3 POIESIS trial is set to investigate navtemadlin as an add-on therapy to Jakafi in patients with JAK inhibitor-naive myelofibrosis. Read More
by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles The strongest connections I’ve made are with others who have also been through their own cancer journeys. Read More
by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods. Read More
by MM360 Staff | May 5, 2025 | Uncategorized
Source: CureToday articles First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and neck squamous cell carcinoma. Read More
